Skip to content

Clinical trials

Anemia, Refractory trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Anemia, Refractory Clear all

95 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20007
200110
20023
20036
20042
20059
20067
20078
20081
20095
20103
20112
20131
20151
20182
20221

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed71
Terminated14
Unknown status7
Active, not recruiting1
Recruiting1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Fred Hutchinson Cancer Center11
National Cancer Institute (NCI)8
Masonic Cancer Center, University of Minnesota6
Roswell Park Cancer Institute6
European Organisation for Research and Treatment of Cancer - EORTC4
Case Comprehensive Cancer Center3
Children's Oncology Group3
H. Lee Moffitt Cancer Center and Research Institute3
Memorial Sloan Kettering Cancer Center3
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Anemia, Refractory95
Anemia, Refractory, with Excess of Blasts77
Myelodysplastic Syndromes77
Leukemia58
Leukemia, Myelomonocytic, Chronic57
Leukemia, Myeloid, Acute39
Myeloproliferative Disorders37
Precursor Cell Lymphoblastic Leukemia-Lymphoma37
Leukemia, Lymphocytic, Chronic, B-Cell28
Leukemia, Myeloid, Chronic-Phase28

Trials

Showing 76 to 95 of 95. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.